Cohort 1 of the Ib/IIa trial of allergic rhinitis immunotherapy has been finished, including 8 weeks of follow-up inspection in the clinical trial center.

Cohort 1 of the Ib/IIa trial of allergic rhinitis immunotherapy has been finished, including 8 weeks of follow-up inspection in the clinical trial center.

Cohort 1 of the Ib/IIa trial of allergic rhinitis immunotherapy has been finished, including 8 weeks of follow-up inspection in the clinical trial center.

2019-10-01

Back

This site uses cookies to collect the necessary user browsing behavior so that we can provide you with a better browsing experience. Browse this site, which means you agree with "online privacy declaration."